Cost‐effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program

Abstract

HPV vaccination appears to be a very cost-effective strategy for Punjab state, and is likely to be cost-effective for other Indian states. Cancer 2017;123:3253-60. © 2017 American Cancer Society.

Reply to Cost‐effectiveness calculations of human papillomavirus vaccination in Punjab may be flawed

“…In their letter, Suman and Puliyel question the validity of our findings on the basis of 3 main points. The first point is based on purported differences between our findings and those of Diaz et al Diaz et al stated that when the cost per vaccinated girl reached Int $ 20 (US $6.60), the strategy of vaccination alone became dominated by the strategy of screening alone.…”

The Reply to the letter on the cost‐effectiveness of human papillomavirus in Punjab further distorts the scientific record

“…In our letter, we point out that the cost‐effectiveness calculation of Prinja et al assumes 99.1% mortality for cervical cancer (733 deaths among 740 cases of cervical cancer). The authors in their reply suggest that this is because 51.6% of the cases in India are detected only at stage 3 or 4 when the prognosis is not good.…”

Reply to The Reply to the letter on the cost‐effectiveness of human papillomavirus in Punjab further distorts the scientific record

“…First, in their first letter, Suman and Puliyel posed a question regarding the mortality rate of cervical cancer reported in our article . In our response to their letter, we had undertaken another analysis in which we did not consider the lifetime mortality of cancer, and restricted mortality to the first 5 years.…”